When Covid struck and the quest for a vaccine began, the team at Oxford had a head start in that we were already working with the harmless common cold virus on which the AstraZeneca vaccine is based. ChAdOx — a contraction of ‘chimpanzee’, from which the virus was isolated, ‘adenovirus’ and ‘Oxford’ — is also being used to target diseases such as malaria, rabies, zika and Mers. The virus can get into our cells, but it cannot cause infection or replicate, which means it doesn’t spread through our body or from person to person. Instead, we use it to deliver what we want the body to see and respond to — which in the case of Covid-19 is the spike protein of the coronavirus.
Today, more than 33 million people in the UK have received at least a first dose of a Covid vaccine. It is an impressive achievement, faster than any other large country and faster than the response to any previous disease.
Britain’s best politics newsletters
You get two free articles each week when you sign up to The Spectator’s emails.
Already a subscriber? Log in
Comments
Join the debate, free for a month
Be part of the conversation with other Spectator readers by getting your first month free.
UNLOCK ACCESS Try a month freeAlready a subscriber? Log in